Assess whether management can run this without the founder (68bd29)

Situation

After a Phase II that found groundwater impact, related-party revenue that disappears at close is what buy-side QoE lead can touch in a health-system acquiring a specialty practice. M&A Due Diligence will live with Proceed versus Reprice on this Legal, IP, and Regulatory file.

Decision

Buy-side QoE lead in a health-system acquiring a specialty practice must choose Proceed / Reprice / Walk / Hold using related-party revenue that disappears at close after a Phase II that found groundwater impact.

Hypotheses to test

• The population in related-party revenue that disappears at close is the one a Phase II that found groundwater impact named, so Proceed follows for this Legal, IP, and Regulatory file.
• The population in related-party revenue that disappears at close is adjacent only to a Phase II that found groundwater impact; Reprice is the honest M&A Due Diligence call.
• A health-system acquiring a specialty practice already contained a Phase II that found groundwater impact before related-party revenue that disappears at close arrived; no new Legal, IP, and Regulatory path.
• Provenance on related-party revenue that disappears at close after a Phase II that found groundwater impact is broken; do not pick Proceed or Reprice yet.

Analysis required

• Separate a one-off add-back from a recurring earnings issue in related-party revenue that disappears at close.
• Map reps, earnout mechanics, and integration risk a health-system acquiring a specialty practice would inherit.
• Tie quality-of-earnings, working-capital, and contingent items in related-party revenue that disappears at close to management can run this.
• For this M&A Due Diligence Legal, IP, and Regulatory file, read related-party revenue that disappears at close against a Phase II that found groundwater impact and write the one fact that would move management can run this for buy-side QoE lead.

Recommendation

Choose Proceed / Reprice / Walk / Hold on this M&A Due Diligence / Legal, IP, and Regulatory packet (related-party revenue that disappears at close after a Phase II that found groundwater impact). Lead with the M&A Due Diligence option related-party revenue that disappears at close can support after a Phase II that found groundwater impact, then the two facts that force it, then the Monday action for buy-side QoE lead in a health-system acquiring a specialty practice.